Catalyst Wire Dossier Catalyst Wire Dossier

mFOLFOX

Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for mFOLFOX, covering 2017-02-07 to 2026-04-07. Get the full timeline:

Most recent: Clinical Trial Update: mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma [Phase 3]

See pricing